🇺🇸 FDA
Patent

US 7923215

Process for the measurement of the potency of glatiramer acetate

granted A61KA61K31/198A61K38/02

Quick answer

US patent 7923215 (Process for the measurement of the potency of glatiramer acetate) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Apr 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEVA PHARMACEUTICAL INDUSTRIES, LTD.
Grant date
Tue Apr 12 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K31/198, A61K38/02, A61P, A61P25/00